£107.98

Springer - Burkitt's Lymphoma (Current Cancer Research)

Price data last checked 23 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 68 days • 68 data points (No recent data available)

Historical
Generating forecast...
£107.98 £107.38 £107.51 £107.64 £107.77 £107.90 £108.04 14 March 2026 30 March 2026 16 April 2026 03 May 2026 20 May 2026

Price Distribution

Price distribution over 68 days • 2 price levels

Days at Price
Current Price
45 days 23 days · current 0 11 23 34 45 £107 £108 Days at Price

Price Analysis

Most common price: £107 (45 days, 66.2%)

Price range: £107 - £108

Price levels: 2 different prices over 68 days

Description

Explore the evolution of oncology research with Burkitt's Lymphoma (Current Cancer Research) from Springer. This volume tracks the progress of the field from its initial discovery by Dr. Dennis Burkitt in equatorial Africa during the mid to late 1950s through to modern advancements. This text offers a deep look into the molecular changes that drive the initiation and development of this disease. It serves as a vital resource for medical professionals and researchers seeking a comprehensive view of the condition. Readers can expect insights ranging from initial diagnosis to the study of potential animal models used in research. By including perspectives from physicians who work directly with patients in regions where the disease is rampant, this book bridges the gap between laboratory science and clinical practice. It provides a complete overview of the current understanding of Burkitt's lymphoma for those studying internal medicine and oncology.

Key Features

Provides a comprehensive view of Burkitt's lymphoma from the initial stages of diagnosis to the study of potential animal models.

Includes clinical perspectives from physicians working directly with patient populations where the disease is most rampant.

Covers the historical context of the disease starting from its discovery in equatorial Africa by Dr. Dennis Burkitt.

Details the molecular changes linked to the initiation and development of Burkitt's lymphoma for advanced research purposes.

Serves as a specialized resource for medical practitioners and researchers focused on oncology and internal medicine.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
28 January 2015
Listed Since
29 January 2015

Barcode

No barcode data available

Similar Products You Might Like

Burkitt’s Lymphoma (Current Cancer Research)
99% match

Burkitt’s Lymphoma (Current Cancer Research)

Springer

£110.02 29 May 2026
Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology
96% match

Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology

Humana

£101.00 18 Apr 2026
Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)
96% match

Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)

Springer

£148.67 11 Jun 2026
Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)
96% match

Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)

Springer

£77.39 11 Mar 2026
Springer Hodgkin's and Non-Hodgkin's Lymphoma - Research Book
96% match

Springer Hodgkin's and Non-Hodgkin's Lymphoma - Research Book

Springer

£46.26 15 May 2026
Aggressive Lymphomas (Hematologic Malignancies)
96% match

Aggressive Lymphomas (Hematologic Malignancies)

Springer

£88.97 08 Mar 2026
Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)
96% match

Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)

Humana

£141.36 01 Mar 2026
Rare Lymphomas (Hematologic Malignancies)
96% match

Rare Lymphomas (Hematologic Malignancies)

Springer

£96.52 11 Jun 2026
Saunders Extranodal Lymphomas: Expert Consult - Online and Print
96% match

Saunders Extranodal Lymphomas: Expert Consult - Online and Print

Saunders

£98.71 16 May 2026
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
96% match

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Springer

£91.64 25 Apr 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
96% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£122.35 09 Mar 2026
Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)
96% match

Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)

Springer

£69.58 07 Mar 2026
Humana Lymphoma: Diagnosis and Treatment - Clinical Oncology 43
96% match

Humana Lymphoma: Diagnosis and Treatment - Clinical Oncology 43

Humana

£141.51 20 May 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
96% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£88.34 09 Mar 2026
Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)
96% match

Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)

Springer

£77.82 11 Mar 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
96% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£398.50 13 Jan 2026
An Illustrated Guide to Skin Lymphoma Diagnosis
96% match

An Illustrated Guide to Skin Lymphoma Diagnosis

Wiley-Blackwell

£72.50 20 May 2026
Skin Lymphoma: The Illustrated Guide
96% match

Skin Lymphoma: The Illustrated Guide

Wiley-Blackwell

£100.68 23 Jan 2026
Springer Malignant Lymphomas and Hodgkin's Disease Volume 66
96% match

Springer Malignant Lymphomas and Hodgkin's Disease Volume 66

Springer

£120.99 16 May 2026
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
96% match

Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)

Humana

£117.00 28 Feb 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
96% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£291.99 11 Jan 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
96% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£244.99 14 Jan 2026
Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research)
96% match

Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research)

Springer

£121.94 12 Jun 2026
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
96% match

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Springer

£76.09 02 May 2026